More blood cancer drugs move falls short, says Dr Rodger Tiedemann

Close to 4000 people with blood cancer and blood-related disorders are expected to benefit from a move to buy more medicines, but a haematologist says New Zealanders will continue to die early until more modern medicines are funded.

Dr Rodger Tiedemann said the announcement reflected “one small step for patients, one giant deal for Pharmac,”.

Read more here: here